Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a global biopharmaceutical enterprise focused on enhancing health through the creation, production, and distribution of an extensive array of generic and specialized pharmaceutical products. Op…
HQ: Bridgewater, NJ, United States of Americawww.amneal.com
USD21.38-1.47%vs prev. close
Performance
1W
+11.57%
1M
+10.88%
3M
+25.65%
1Y
+82.35%
YTD
+72.22%
Valuation
P/E
54.3
EPS TTM
0.40
Dividend yield
—
Size and risk
Market cap
$7.6B
Beta
1.21
Price history
AMRX price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Amneal Pharmaceuticals
AMRX
Drug Manufacturers - Specialty & Generic
Mkt cap (USD bn)
7.6
P/E
54.3
Div yld
—
1W
+11.6%
1M
+10.9%
3M
+25.6%
6M
+77.4%
1Y
+82.3%
YTD
+72.2%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Amneal Pharmaceuticals
AMRX
Drug Manufacturers - Specialty & Generic
7.6
54.3
—
+11.6%
+10.9%
+25.6%
+77.4%
+82.3%
+72.2%
Subscribe to Equity Analytics to compare AMRX with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.